OVERVIEW

American Association for Cancer Research (AACR) Annual Meeting 2021 is organized by American Association for Cancer Research (AACR) and will be held from Apr 10 - May 21, 2021.

Session Details:
• Week 1: April 10-15, 2021;
• Week 2: May 17-21, 2021

Accreditation:
Credit Designation Statement:
AACR has designated the AACR Annual Meeting 2021 internet live activity for a maximum of 215 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 215 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Description:
The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.

The fight against cancer is rapidly progressing with the accelerating pace of discoveries in the basic, translational, and clinical sciences. This is due in large part to the advent of new technologies, such as advanced live imaging techniques and liquid biopsies, and our increased understanding of the importance of harnessing the power of the immune system to develop new immunotherapies. However, understanding and combating the processes of cancer initiation, progression, and response to treatment require a multidisciplinary approach.

By bridging the gap between what physicians understand about cancer biology and the clinical applications, this meeting aids basic researchers, physicians, and clinician-scientists in obtaining, synthesizing, and integrating the most current molecular-based tests to aid in the diagnosis, treatment, and prevention of cancer. Further, facilitating the interface between physicians and scientists increases the contributions of laboratory research to drug development as well as patient care, transforms the design and conduct of clinical research protocols, and creates an avenue for the rapid translation of laboratory research findings from “bench-to-bedside” for the benefit of improving patient outcomes. This meeting also acts as a forum to discuss cancer health disparities and help ensure that all patients benefit from emerging breakthroughs in research and cancer treatment.

Objectives:
After participating in this CME activity, physicians should be able to:
• Assess the technological advances and tools, such as liquid biopsies, being used to accelerate progress in cancer research and improve early detection and early interception, with the ultimate goal of extending patients’ lives and improving their quality of life.
• Articulate how advances in precision cancer medicine are leading to improved patient outcomes.
• Incorporate the latest research findings regarding therapies and treatment options, including immunotherapy and combination therapies, in a variety of cancer types to improve patient outcomes.
• Formulate new strategies integrating multidisciplinary scientific and clinical research efforts towards the prevention, early detection, and interception of cancer.
• Identify factors that impact the diagnosis, treatment, and prevention of various forms of cancers in patients from diverse populations.
• Develop collaborations among physicians, researchers, and clinician-scientists to advance approaches for cancer treatment and prevention.